Stock listing

NASDAQ:VCEL Vericel Corporation Stock

Home listing (NASDAQ) of Vericel Corporation

Follow Vericel Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:VCEL

$57.52 USD -1.13 (-1.9%)

Close on Nov 20, 2026

Past year +52.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$57.33 – $59.49 USDNov 20, 2026
Volume
582,315 sharesNov 20, 2026
Market cap
$2.94B USDAt the close on Nov 20, 2026 · price × 51.03M shares outstanding
52-week range
$28.95 – $59.75 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$30.08M USDMedian day 567,700 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Vericel Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:VCEL · Home$57.52 USD-1.13 (-1.9%)582,315$58.11$59.49$57.33$58.65Close on Nov 20, 2026
Frankfurt:ATQP€53.50 EUR0.00 (0.0%)—€52.50€53.50€52.50€53.50Close on Nov 20, 2026
Munich:ATQP€53.00 EUR-0.50 (-0.9%)—€53.00€53.00€53.00€53.50Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:VCEL · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$57.52-1.13-1.9%$58.11$59.49$57.33582,315
$58.65+0.77+1.3%$57.88$59.57$57.75832,429
$57.88+0.40+0.7%$57.48$58.68$57.32555,302
$57.48+0.52+0.9%$56.85$58.63$56.71972,843
$56.96-0.46-0.8%$57.66$58.42$56.86698,340
$57.42-2.03-3.4%$59.50$59.50$56.92826,521
$59.45+0.42+0.7%$58.50$59.75$57.85809,203
$59.03+0.64+1.1%$58.39$59.72$57.831,331,156
$58.39+3.77+6.9%$56.00$59.48$55.601,750,519
$54.62+2.84+5.5%$51.79$54.64$50.761,612,301
$51.78+6.30+13.9%$50.54$55.60$49.002,677,363
$45.48+4.39+10.7%$42.07$45.98$42.071,742,273
$41.09+0.58+1.4%$40.52$41.50$40.36635,179
$40.51+0.25+0.6%$40.29$40.88$39.44684,368
$40.26-2.65-6.2%$43.02$43.02$40.01598,732
$42.91+1.82+4.4%$41.99$43.05$41.48544,830
$41.09-2.18-5.0%$43.05$43.50$40.59680,183
$43.27+0.23+0.5%$43.04$43.74$42.65558,356
$43.04+0.51+1.2%$42.73$43.83$42.30634,752
$42.53-0.44-1.0%$42.99$43.00$41.75494,700
$42.97+2.03+5.0%$41.21$43.01$40.02604,900
$40.94+0.36+0.9%$40.00$41.04$40.00432,000
$40.58+0.21+0.5%$40.81$41.03$39.97475,300
$40.37+0.24+0.6%$40.36$40.95$40.04334,200
$40.13-0.89-2.2%$41.07$41.55$39.71737,100
$41.02+0.77+1.9%$40.77$41.60$40.26601,200
$40.25-0.05-0.1%$39.90$40.31$39.60384,500
$40.30-0.32-0.8%$40.62$40.77$39.99511,700
$40.62+0.52+1.3%$40.30$40.81$39.00432,900
$40.10+0.05+0.1%$39.83$41.13$39.78506,900
$40.05-0.69-1.7%$40.53$40.94$39.81749,100
$40.74+0.69+1.7%$39.67$41.40$39.50647,000
$40.05-1.02-2.5%$41.38$41.45$39.65669,000
$41.07+0.92+2.3%$40.13$41.17$39.93648,600
$40.15+0.71+1.8%$40.01$40.40$39.37479,200
$39.44-0.70-1.7%$40.27$40.72$39.29497,300
$40.14-0.47-1.2%$40.79$41.08$39.82585,400
$40.61+0.37+0.9%$40.27$40.83$39.93526,900
$40.24+0.53+1.3%$39.78$41.05$39.65643,100
$39.71+0.41+1.0%$39.30$39.80$38.74359,300
$39.30+0.51+1.3%$38.86$39.40$38.39352,000
$38.79-1.43-3.6%$39.95$40.10$38.21434,000
$40.22+0.67+1.7%$40.00$40.42$39.55547,000
$39.55-0.47-1.2%$40.08$40.29$39.05402,200
$40.02-0.010.0%$39.80$40.21$39.571,126,500
$40.03-0.18-0.4%$40.62$40.62$39.06536,400
$40.21+0.49+1.2%$39.73$40.87$39.73490,500
$39.72+0.12+0.3%$39.39$40.15$38.55654,800
$39.60+1.26+3.3%$38.58$39.70$38.20629,400
$38.34+0.47+1.2%$38.39$38.95$37.35503,500
$37.87-1.12-2.9%$38.56$38.82$37.67340,200
$38.99-0.09-0.2%$38.72$39.19$38.53366,500
$39.08-1.11-2.8%$39.69$39.72$38.74410,300
$40.19-0.28-0.7%$40.04$40.57$39.85312,900
$40.47-0.42-1.0%$41.30$41.30$40.09301,300
$40.89+0.39+1.0%$40.49$41.49$40.35395,500
$40.50+0.60+1.5%$39.87$41.44$39.66651,100
$39.90-1.05-2.6%$40.48$40.88$39.34636,300
$40.95-0.23-0.6%$41.18$41.47$40.51491,200
$41.18-1.26-3.0%$42.39$42.65$41.16533,500
$42.44-0.78-1.8%$43.22$43.22$42.33313,600
$43.22+0.92+2.2%$42.95$43.25$42.53465,742
$42.30-0.38-0.9%$42.68$43.34$41.95812,270
$42.68+0.57+1.4%$42.36$42.85$41.76647,100
$42.11-1.46-3.4%$42.83$43.48$41.68567,700

Splits

2 splits since 2010 · NASDAQ:VCEL · every price before a split is adjusted for it

DayRatioWhat
1-for-20Consolidation
1-for-8Consolidation
Ticker
NASDAQ:VCEL
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Vericel Corporation news

Vericel Corporation on 6ix

News releases
15 in the last 12 months · 138 in all · newest Nov 13, 2026 · oldest 2019
Calls
25 calls with a replay · 25 with a transcript · latest Nov 5, 2026
Decks
40 decks · latest November 2026

Where Vericel Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:VCEL · Home listing · This pageNASDAQUnited StatesUSD
LS Exchange:A12FU4LS ExchangeGermanyEUR
gettex:ATQPgettexGermanyEUR
Lang & Schwarz:A12FU4Lang & SchwarzGermanyEUR
Dusseldorf:ATQPDusseldorfGermanyEUR
Frankfurt:ATQPFrankfurtGermanyEUR
Munich:ATQPMunichGermanyEUR
Stuttgart:ATQPStuttgartGermanyEUR
Tradegate:ATQPTradegateGermanyEUR
BOATS:VCELBOATSUnited StatesUSD

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$2.86B USD
P/E
88.1×
EV/sales
8.8×
EV/EBITDA
70.3×
Price/book
7.6×
Gross margin
74.5%
Operating margin
8.3%
Net margin
10.3%
Debt to equity
0.2×
Beta vs S&P 500
0.49

Forecasts

7 strong buy · 1 hold · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
65.43 USD · Analysts' mean
EPS, year to Dec 2026
0.75 · 5 analysts
Revenue, year to Dec 2026
345.3M · 8 analysts

Team and board

Officers

OfficerRole
Dominick ColangeloPresident and Chief Executive Officer
Michael BanffyCEO
Joseph A. MaraChief Financial Officer

Board

DirectorRole
Robert L. ZerbeChairman of the Board
Alan L. RubinoDirector
Heidi HagenDirector
Kevin McLaughlinDirector
Lisa WrightDirector
Paul WottonDirector

Events

Calls

CallWhenStatus
Vericel (NASDAQ:VCEL) Q3 2026 Earnings CallThu, Nov 05, 2026 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q2 2026 Earnings CallThu, Jul 30, 2026 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q1 2026 Earnings CallThu, May 07, 2026 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q4 2025 Earnings CallThu, Feb 26, 2026 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q3 2025 Earnings CallThu, Nov 06, 2025 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q2 2025 Earnings CallThu, Jul 31, 2025 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q1 2025 Earnings CallThu, May 08, 2025 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q4 2024 Earnings CallThu, Feb 27, 2025 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q3 2024 Earnings CallThu, Nov 07, 2024 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q2 2024 Earnings CallThu, Aug 01, 2024 · 8:30 AM ETReplay
All 25 calls
CallWhenStatus
Vericel (NASDAQ:VCEL) Q1 2024 Earnings CallWed, May 08, 2024 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q4 2023 Earnings CallThu, Feb 29, 2024 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q3 2023 Earnings CallWed, Nov 08, 2023 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q2 2023 Earnings CallWed, Aug 02, 2023 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q1 2023 Earnings CallWed, May 10, 2023 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q4 2022 Earnings CallThu, Feb 23, 2023 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q3 2022 Earnings CallWed, Nov 09, 2022 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q2 2022 Earnings CallWed, Aug 03, 2022 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q1 2022 Earnings CallWed, May 04, 2022 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q4 2021 Earnings CallThu, Feb 24, 2022 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q3 2021 Earnings CallTue, Nov 09, 2021 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q2 2021 Earnings CallWed, Aug 04, 2021 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q1 2021 Earnings CallWed, May 05, 2021 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q4 2020 Earnings CallWed, Feb 24, 2021 · 8:30 AM ETReplay
Vericel (NASDAQ:VCEL) Q3 2020 Earnings CallThu, Nov 05, 2020 · 8:30 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · Before open+13.8%
Q2 2026Jul 30, 2026 · Before open+2.1%
Q1 2026May 7, 2026 · Before open−4.5%
Q4 2025Feb 26, 2026−3.8%
Q3 2025Nov 6, 2025 · Before open+4.2%
Q2 2025Jul 31, 2025 · Before open−14.1%
Q1 2025May 8, 2025 · Before open+3.5%
Q4 2024Feb 26, 2025 · Before open+0.6%
Q3 2024Nov 7, 2024 · Before open+4.1%
Q2 2024Aug 1, 2024 · Before open−5.9%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · Before open−3.7%
Q4 2023Feb 29, 2024 · Before open−4.4%
Q3 2023Nov 8, 2023 · Before open−3.4%
Q2 2023Aug 2, 2023 · Before open−1.4%
Q1 2023May 10, 2023 · Before open+4.1%
Q4 2022Feb 23, 2023 · Before open+7.3%
Q3 2022Nov 9, 2022 · Before open−23.4%
Q2 2022Aug 3, 2022 · Before open−0.3%
Q1 2022May 4, 2022 · Before open−1.0%
Q4 2021Feb 24, 2022 · Before open+20.8%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck25 slidesNovember 2026
Investor Presentation (August 2026)Investor deck25 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings10 slidesMay 7, 2026
Q4 2025 Earnings PresentationEarnings8 slidesFeb 26, 2026
Q3 2025 Earnings PresentationEarnings6 slidesNov 6, 2025
Investor Presentation (November 2025)Investor deck25 slidesNovember 2025
Q2 2025 Earnings PresentationEarnings7 slidesJul 31, 2025
Q1 2025 Earnings PresentationEarnings8 slidesMay 8, 2025
Q4 2024 Earnings PresentationEarnings12 slidesFeb 27, 2025
43rd Annual J.P. Morgan Healthcare Conference (January 2025)Conference25 slidesJan 14, 2025
All 40 decks
DeckKindSlidesDate
Q3 2024 Earnings PresentationEarnings8 slidesNov 7, 2024
Investor Presentation (September 2024)Investor deck24 slidesSeptember 2024
Q2 2024 Earnings PresentationEarnings8 slidesAug 1, 2024
Q1 2024 Earnings PresentationEarnings8 slidesMay 8, 2024
Q4 2023 Earnings PresentationEarnings11 slidesFeb 29, 2024
42nd Annual J.P. Morgan Healthcare Conference 2024Conference26 slidesJan 9, 2024
Q3 2023 Earnings PresentationEarnings10 slidesNov 8, 2023
Investor Presentation (November 2023)Investor deck27 slidesNovember 2023
Q2 2023 Earnings PresentationEarnings12 slidesAug 2, 2023
Q1 2023 Earnings PresentationEarnings10 slidesMay 10, 2023
41st Annual J.P. Morgan Healthcare Conference 2023Conference27 slidesJan 10, 2023
Investor Presentation (March 2022)Investor deck23 slidesMarch 2022
Investor Presentation (January 2022)Investor deck23 slidesJan 12, 2022
Investor Presentation (April 2021)Investor deck28 slidesApril 2021
Investor Presentation (January 2018)Investor deck29 slidesJan 8, 2018
Investor Presentation (April 2016)Investor deck36 slidesApr 12, 2016
Technical Presentation (April 2016)Technical32 slidesApril 2016
Investor Presentation (January 2015)Investor deck29 slidesJan 12, 2015
Aastrom Biosciences — IPO Roadshow (August 2013)IPO roadshow33 slidesAug 7, 2013
Technical Presentation (May 2013)Technical13 slidesMay 2013
Aastrom Biosciences — Investor Presentation (April 2013)Investor deck25 slidesApr 23, 2013
Aastrom Biosciences — American Heart Association Scientific Sessions 2011Conference24 slidesNov 14, 2011
Aastrom Biosciences — Technical Presentation (November 2010)Technical31 slidesNov 19, 2010
Aastrom Biosciences — Investor Presentation (January 2010)Investor deck20 slidesJan 8, 2010
Aastrom Biosciences — Investor Presentation (June 2006)Investor deck26 slidesJun 26, 2006
Aastrom Biosciences — Technical Presentation (March 2006)Technical46 slidesMar 22, 2006
Aastrom Biosciences — Shareholder Meeting (November 2005)Shareholder meeting36 slidesNov 2, 2005
Aastrom Biosciences — Investor Presentation (August 2005)Investor deck26 slidesAug 26, 2005
Aastrom Biosciences — Investor Presentation (March 2005)Investor deck31 slidesMar 15, 2005
Aastrom Biosciences — Investor Presentation (September 2003)Investor deck31 slidesSep 15, 2003

Open Decks

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue276.3M237.2M197.5M164.4M156.2M124.2M117.8M90.9M63.9M54.4M
Cost of revenue70.7M65.1M61.9M54.6M50.2M40.0M37.6M32.2M30.4M28.3M
Gross profit205.6M172.1M135.6M109.8M106.0M84.2M80.3M58.7M33.6M26.1M
Research and development27.6M24.8M21.0M19.9M16.3M13.0M30.4M13.6M12.9M15.3M
Selling, general and administrative167.0M142.8M121.0M106.9M97.6M68.8M61.1M49.0M35.6M27.4M
Operating income11.0M4.52M-6.46M-17.1M-7.85M2.37M-11.3M-3.91M-15.0M-19.2M
Depreciation and amortization11.5M5.50M4.63M3.98M2.96M2.38M1.70M1.43M1.61M1.89M
EBITDA22.6M10.0M-1.83M-13.1M-4.89M4.75M-9.55M-2.48M-13.4M-17.4M
Interest expense630.0K614.0K600.0K366.0K4.00K6.00K8.00K31.0K92.0K15.0K
Income before tax17.4M10.5M-2.37M-16.0M-7.58M3.04M-9.66M-8.14M-17.3M-19.6M
Income tax859.0K148.0K814.0K721.0K-111.0K180.0K0000
Net income16.5M10.4M-3.18M-16.7M-7.47M2.86M-9.66M-8.14M-17.3M-19.6M
Earnings per share, basic0.330.21-0.07-0.35-0.160.06-0.22-0.20-0.52-1.18
Earnings per share, diluted0.320.20-0.07-0.35-0.160.06-0.22-0.20-0.52-1.18

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents100.1M74.5M69.1M51.1M68.3M33.6M26.9M18.3M26.9M23.0M
Short-term investments37.4M41.7M40.5M68.5M35.1M42.2M42.8M64.6M00
Receivables84.6M61.4M58.4M46.5M37.4M34.5M32.2M23.5M18.3M17.1M
Inventory17.6M17.4M13.1M16.0M13.4M9.36M6.82M3.56M3.79M3.49M
Current assets247.4M212.8M205.6M186.9M158.5M123.6M111.7M112.8M50.5M44.7M
Property, plant and equipment57.4M59.0M57.7M32.2M5.91M4.07M3.88M
Goodwill00
Total assets488.0M432.7M353.7M273.0M243.7M205.6M153.2M118.7M54.6M48.6M
Accounts payable15.8M23.8M22.3M16.9M9.02M6.75M6.34M7.11M5.55M6.54M
Current liabilities49.1M50.3M45.7M37.5M26.1M22.5M19.8M14.8M13.1M12.9M
Long-term debt16.9M9.32M
Total debt98.3M98.8M88.0M47.6M50.2M53.3M27.9M16.9M9.32M
Total liabilities133.3M140.8M127.7M80.7M73.2M71.3M42.1M16.5M32.0M23.9M
Shareholders' equity354.6M292.0M226.0M192.3M170.5M134.3M111.1M102.2M22.5M24.7M
Shares outstanding50.6M49.6M47.8M47.3M46.9M45.8M44.9M43.6M35.9M31.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations51.9M58.2M35.3M17.7M29.0M17.6M-7.18M-412.0K-13.2M-19.9M
Capital spending-27.2M-64.0M-20.0M-7.60M-7.92M-2.63M-2.62M-2.68M-1.51M-1.42M
Free cash flow24.7M-5.81M15.3M10.1M21.1M14.9M-9.80M-3.09M-14.7M-21.3M
Cash from investing-43.9M-79.0M-3.13M-36.2M-3.50M-17.2M10.6M-67.0M-1.51M-1.42M
Cash from financing7.07M19.1M3.62M1.04M9.17M6.44M5.26M58.9M18.6M29.7M
Dividends paid00
Share buybacks3.65M11.2M6.63M5.29M77.1M12.4M19.5M
Change in cash15.0M-1.82M35.8M-17.5M34.7M6.85M8.69M-8.58M3.88M8.40M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 17, 2026Insider tradeSEC
144 · Notice of proposed saleNov 13, 2026Other filingsSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
4 · Change in ownershipNov 12, 2026Insider tradeSEC
144 · Notice of proposed saleNov 12, 2026Other filingsSEC
144 · Notice of proposed saleNov 10, 2026Other filingsSEC
144 · Notice of proposed saleNov 9, 2026Other filingsSEC
144 · Notice of proposed saleNov 9, 2026Other filingsSEC
4 · Change in ownershipNov 9, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
144/A · Notice of proposed sale, amendedNov 6, 2026Other filingsSEC
144 · Notice of proposed saleNov 6, 2026Other filingsSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
4 · Change in ownershipAug 14, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2026Big-stake noticeSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
4 · Change in ownershipAug 5, 2026Insider tradeSEC
144 · Notice of proposed saleAug 3, 2026Other filingsSEC
4 · Change in ownershipJul 31, 2026Insider tradeSEC
144 · Notice of proposed saleJul 30, 2026Other filingsSEC
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
8-K · Current reportJul 30, 2026ResultsSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
4 · Change in ownershipJun 30, 2026Insider tradeSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
144 · Notice of proposed saleJun 18, 2026Other filingsSEC
144 · Notice of proposed saleJun 18, 2026Other filingsSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
144 · Notice of proposed saleJun 2, 2026Other filingsSEC
8-K · Current reportMay 18, 2026Current reportSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
4 · Change in ownershipMay 13, 2026Insider tradeSEC
144 · Notice of proposed saleMay 13, 2026Other filingsSEC
144 · Notice of proposed saleMay 11, 2026Other filingsSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
4 · Change in ownershipMay 8, 2026Insider tradeSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
144 · Notice of proposed saleMay 7, 2026Other filingsSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
144 · Notice of proposed saleMay 6, 2026Other filingsSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
8-K · Current reportMay 1, 2026Meeting outcomeSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
4 · Change in ownershipApr 6, 2026Insider tradeSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeApr 1, 2026Big-stake noticeSEC
4 · Change in ownershipMar 27, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
144 · Notice of proposed saleMar 23, 2026Other filingsSEC
DEFA14A · Additional proxy materialMar 19, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 19, 2026Meeting noticeSEC
ARS · Annual report to shareholdersMar 19, 2026Annual reportSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
4 · Change in ownershipFeb 26, 2026Insider tradeSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
4 · Change in ownershipFeb 20, 2026Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2026Insider tradeSEC
4 · Change in ownershipFeb 13, 2026Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2026Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2026Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2026Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 11, 2026Other filingsSEC
8-K · Current reportJan 13, 2026ResultsSEC
4 · Change in ownershipJan 9, 2026Insider tradeSEC
144 · Notice of proposed saleJan 7, 2026Other filingsSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
4 · Change in ownershipDec 4, 2025Insider tradeSEC
144 · Notice of proposed saleDec 3, 2025Other filingsSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 12, 2025Big-stake noticeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
4 · Change in ownershipNov 10, 2025Insider tradeSEC
144 · Notice of proposed saleNov 10, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeNov 10, 2025Big-stake noticeSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
144 · Notice of proposed saleSep 2, 2025Other filingsSEC
4 · Change in ownershipAug 8, 2025Insider tradeSEC
144 · Notice of proposed saleAug 6, 2025Other filingsSEC
10-Q · Quarterly reportJul 31, 2025Quarterly reportSEC
8-K · Current reportJul 31, 2025ResultsSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
144 · Notice of proposed saleJun 2, 2025Other filingsSEC
144 · Notice of proposed saleMay 30, 2025Other filingsSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
144 · Notice of proposed saleMay 15, 2025Other filingsSEC
144 · Notice of proposed saleMay 14, 2025Other filingsSEC
4 · Change in ownershipMay 9, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMay 8, 2025Offer documentSEC
S-8 · Registration statement for employee plansMay 8, 2025Offer documentSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
144 · Notice of proposed saleMay 7, 2025Other filingsSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
8-K · Current reportMay 2, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedApr 30, 2025Big-stake noticeSEC
8-K · Current reportApr 14, 2025Current reportSEC
4 · Change in ownershipApr 11, 2025Insider tradeSEC
144 · Notice of proposed saleApr 10, 2025Other filingsSEC
144 · Notice of proposed saleApr 9, 2025Other filingsSEC
DEFA14A · Additional proxy materialMar 20, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 20, 2025Meeting noticeSEC
ARS · Annual report to shareholdersMar 20, 2025Annual reportSEC
4 · Change in ownershipMar 14, 2025Insider tradeSEC
144 · Notice of proposed saleMar 13, 2025Other filingsSEC
144 · Notice of proposed saleMar 12, 2025Other filingsSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
10-K · Annual reportFeb 27, 2025Annual reportSEC
8-K · Current reportFeb 27, 2025ResultsSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
4 · Change in ownershipFeb 26, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 25, 2025Other filingsSEC
144 · Notice of proposed saleFeb 25, 2025Other filingsSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 24, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
4 · Change in ownershipFeb 20, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 20, 2025Other filingsSEC
3 · Initial statement of ownershipFeb 19, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 19, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2025Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2025Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2025Insider tradeSEC
5 · Annual statement of ownershipFeb 13, 2025Insider tradeSEC
144 · Notice of proposed saleFeb 12, 2025Other filingsSEC
4 · Change in ownershipFeb 11, 2025Insider tradeSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Vericel Corporation’s releases · as of Oct 29, 2026

Common shares
51,029,770
Fully diluted
51,029,770

Fully diluted

LineSharesAs of
Common shares51,029,770Oct 29, 2026

Share count over time

CountShares
Oct 29, 202651,029,770

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
BlackRock8.17MUS$328MSep 30, 2026
Vanguard3.76MUS$151MSep 30, 2026
State Street3.2MUS$129MSep 30, 2026
Congress Asset Management Co2.55MUS$102MSep 30, 2026
William Blair Investment Management, LLC1.96MUS$78.7MSep 30, 2026
BNP Paribas1.79MUS$71.7MSep 30, 2026
Conestoga Capital Advisors, LLC1.57MUS$63.1MSep 30, 2026
Soleus Capital Management, L.P.1.55MUS$62.4MSep 30, 2026
GW&K Investment Management, LLC1.54MUS$61.7MSep 30, 2026
Geode Capital1.4MUS$56.2MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Geneva Capital Management LLC1.3MUS$52.1MSep 30, 2026
Loomis Sayles & Co L P1.22MUS$49MSep 30, 2026
Bank of America1.03MUS$41.3MSep 30, 2026
Dimensional968KUS$38.9MSep 30, 2026
Goldman Sachs902KUS$36.2MSep 30, 2026
Silvercrest Asset Management Group LLC818KUS$32.8MSep 30, 2026
Two Sigma809KUS$32.5MSep 30, 2026
RBC782KUS$31.4MSep 30, 2026
Next Century Growth Investors LLC709KUS$28.4MSep 30, 2026
abrdn698KUS$28MSep 30, 2026
Nomura661KUS$26.5MSep 30, 2026
Nuveen616KUS$24.7MSep 30, 2026
Northern Trust584KUS$23.5MSep 30, 2026
Schwab560KUS$22.5MSep 30, 2026
Morgan Stanley552KUS$22.2MSep 30, 2026
SG Capital Management LLC517KUS$20.7MSep 30, 2026
TimesSquare Capital Management, LLC486KUS$19.5MSep 30, 2026
Champlain Investment Partners, LLC479KUS$19.2MSep 30, 2026
Raymond James Financial Inc459KUS$18.4MSep 30, 2026
D. E. Shaw & Co., Inc.454KUS$18.2MSep 30, 2026
Balyasny Asset Management L.P.446KUS$17.9MSep 30, 2026
Sei Investments Co435KUS$17.4MSep 30, 2026
UBS410KUS$16.4MSep 30, 2026
Invesco403KUS$16.2MSep 30, 2026
Qube Research & Technologies Ltd388KUS$15.6MSep 30, 2026
Brown Capital Management LLC341KUS$13.7MSep 30, 2026
Janus Henderson340KUS$13.6MSep 30, 2026
AQR Capital Management LLC336KUS$13.5MSep 30, 2026
Principal335KUS$13.5MSep 30, 2026
Public Sector Pension Investment Board312KUS$12.6MSep 30, 2026
Frontier Capital Management Co LLC310KUS$12.4MSep 30, 2026
Federated Hermes, Inc.301KUS$12.1MSep 30, 2026
Envestnet Asset Management Inc300KUS$12MSep 30, 2026
Osterweis Capital Management Inc298KUS$11.9MSep 30, 2026
Rice Hall James & Associates, LLC280KUS$11.2MSep 30, 2026
JPMorgan278KUS$11.4MSep 30, 2026
Woodline Partners LP276KUS$11.1MSep 30, 2026
BNY275KUS$11MSep 30, 2026
Peregrine Capital Management LLC199KUS$7.97MSep 30, 2026
Osaic Holdings, Inc.196KUS$7.86MSep 30, 2026

This page holds 50 of 312 holders. Open Shareholders

Funds

HolderSharesValueAs of
iShares Core S&P Small-Cap ETF3.08MUS$137MJun 30, 2026
Vanguard Total Stock Market Index Fund1.62MUS$71.9MJun 30, 2026
iShares Russell 2000 ETF1.34MUS$59.5MJun 30, 2026
Conestoga Small Cap Fund1.31MUS$58.2MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1.19MUS$53.1MJun 30, 2026
Congress Small Cap Growth Fund1.09MUS$50.1MJul 31, 2026
Loomis Sayles Small Cap Growth Fund649KUS$28.9MJun 30, 2026
Vanguard Extended Market Index Fund584KUS$26MJun 30, 2026
Fidelity Small Cap Index Fund563KUS$25.9MJul 31, 2026
iShares Russell 2000 Growth ETF476KUS$21.2MJun 30, 2026
Show 50 holders
HolderSharesValueAs of
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF470KUS$20.9MJun 30, 2026
William Blair Small Cap Growth Fund469KUS$20.9MJun 30, 2026
iShares S&P Small-Cap 600 Growth ETF459KUS$20.4MJun 30, 2026
Nomura Small Cap Growth Fund407KUS$18.1MJun 30, 2026
Brown Capital Management Small Company Fund373KUS$16.6MJun 30, 2026
Nationwide Geneva Small Cap Growth Fund371KUS$17MJul 31, 2026
iShares Biotechnology ETF358KUS$15.9MJun 30, 2026
Vanguard Tax-Managed Small-Cap Fund313KUS$13.9MJun 30, 2026
Osterweis Opportunity Fund304KUS$13.5MJun 30, 2026
Champlain Small Company Fund299KUS$13.3MJun 30, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF294KUS$13.1MJun 30, 2026
Nuveen Quant Small Cap Equity Fund288KUS$13.2MJul 31, 2026
Fidelity Extended Market Index Fund262KUS$8.74MMay 31, 2026
Vanguard Russell 2000 Index Fund259KUS$8.63MMay 31, 2026
Schwab U.S. Small-Cap ETF244KUS$8.14MMay 31, 2026
Janus Henderson Small/Mid Cap Growth Alpha ETF236KUS$10.9MJul 31, 2026
Federated Hermes Kaufmann Small Cap Fund232KUS$10.6MJul 31, 2026
Small Cap Equity Portfolio222KUS$10.2MJul 31, 2026
Bridge Builder Small/Mid Cap Growth Fund213KUS$9.47MJun 30, 2026
U.S. Small Cap Portfolio212KUS$9.76MJul 31, 2026
Invesco Biotechnology & Genome ETF200KUS$9.21MJul 31, 2026
U.S. Micro Cap Portfolio185KUS$8.52MJul 31, 2026
Vanguard S&P Small-Cap 600 Index Fund175KUS$5.85MMay 31, 2026
AMG GW&K Small/Mid Cap Core Fund168KUS$7.46MJun 30, 2026
Dimensional U.S. Small Cap ETF154KUS$7.1MJul 31, 2026
Vanguard Health Care Index Fund152KUS$5.06MMay 31, 2026
AST Small-Cap Equity Portfolio130KUS$5.79MJun 30, 2026
Schwab Small-Cap Index Fund125KUS$5.76MJul 31, 2026
First Trust Small Cap Growth AlphaDEX Fund116KUS$5.34MJul 31, 2026
Multi-Manager Small Cap Equity Strategies Fund113KUS$3.77MMay 31, 2026
Mercer US Small/Mid Cap Equity Fund108KUS$4.82MJun 30, 2026
Loomis Sayles Small Cap Growth Portfolio103KUS$4.59MJun 30, 2026
JNL Multi-Manager Small Cap Value Fund96,218US$4.28MJun 30, 2026
Master Small Cap Index Series93,825US$4.17MJun 30, 2026
Fidelity Total Market Index Fund93,340US$3.11MMay 31, 2026
Nuveen Quant Small/Mid Cap Equity Fund90,300US$4.15MJul 31, 2026
Buffalo Small Cap Growth Fund88,880US$3.95MJun 30, 2026
Dimensional U.S. Core Equity 2 ETF87,592US$4.03MJul 31, 2026
William Blair Small-Mid Cap Core Fund84,909US$3.78MJun 30, 2026
Moa Small Cap Growth Fund81,386US$3.62MJun 30, 2026

This page holds 50 of 273 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Siegal Jonathan
Officer: Principal Accounting Officer
Sale263USD 57.78US$15,196Nov 13, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale935USD 57.62US$53,875Nov 13, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale687USD 57.80US$39,709Nov 13, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale8USD 59.75US$478Nov 11, 2026
McLaughlin Kevin F
Director
Sale7,000USD 58.96US$413KNov 10, 2026
Zerbe Robert L Md
Director
Sale2,000USD 57.88US$116KNov 9, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale25,000USD 58.26US$1.46MNov 9, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale14,068USD 53.41US$751KNov 6, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale14,573USD 53.43US$779KNov 6, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale10,932USD 53.40US$584KNov 5, 2026
All 37 trades
TradeTradeSharesPriceValueDate
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale10,427USD 53.73US$560KNov 5, 2026
Zerbe Robert L Md
Director
Sale500USD 55.00US$27,500Nov 5, 2026
Zerbe Robert L Md
Director
Sale2,500USD 51.67US$129KNov 5, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale1,500USD 52.90US$79,350Nov 5, 2026
Flynn Sean C.
Officer: Chief Legal Officer
Sale15,000USD 51.92US$779KNov 5, 2026
Zerbe Robert L Md
Director
Sale2,500USD 45.40US$114KNov 4, 2026
McLaughlin Kevin F
Director
Sale7,000USD 44.53US$312KAug 12, 2026
Halpin Michael
Officer: Chief Operating Officer
Sale10,000USD 46.84US$468KAug 3, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale1,500USD 48.90US$73,350Jul 30, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale2,500USD 48.90US$122KJul 30, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale500USD 48.90US$24,450Jul 30, 2026
Flynn Sean C.
Officer: Chief Legal Officer
Sale15,000USD 45.64US$685KJun 26, 2026
Hopper Jonathan Mark
Officer: Chief Medical Officer
Sale5,000USD 45.00US$225KJun 26, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale5,000USD 44.75US$224KJun 26, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale232USD 44.90US$10,417Jun 26, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale2,500USD 44.90US$112KJun 26, 2026
Flynn Sean C.
Officer: Chief Legal Officer
Sale15,000USD 40.21US$603KJun 18, 2026
Halpin Michael
Officer: Chief Operating Officer
Sale10,000USD 40.24US$402KJun 18, 2026
Hopper Jonathan Mark
Officer: Chief Medical Officer
Sale4,375USD 35.00US$153KJun 2, 2026
McLaughlin Kevin F
Director
Sale3,500USD 32.83US$115KMay 13, 2026
McLaughlin Kevin F
Director
Sale3,500USD 32.82US$115KMay 13, 2026
Wotton Paul K
Director
Sale2,500USD 33.05US$82,625May 11, 2026
Wotton Paul K
Director
Sale7,500USD 32.64US$245KMay 11, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale1,422USD 40.50US$57,591May 7, 2026
Mara Joseph Anthony Jr
Officer: Chief Financial Officer
Sale5,000USD 40.50US$203KMay 7, 2026
Siegal Jonathan
Officer: Principal Accounting Officer
Sale3,433USD 38.00US$130KMay 6, 2026
Hopper Jonathan Mark
Officer: Chief Medical Officer
Sale3,472USD 35.00US$122KApr 2, 2026

Big stakes

StakeStakeSharesDateFiling
BlackRock, Inc.15.10%7.57MMar 31, 2025Schedule 13G
State Street Corp5.60%2.81MSep 30, 2025Schedule 13G
Vanguard Capital Management LLC5.11%2.6MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Steven C Gilman
Other companies: Akebia Therapeutics, Inc. (Director · Since at least Dec 12, 2018); Scynexis, Inc. (Director · Since at least Oct 2, 2017); Momenta Pharmaceuticals Inc (Director · Jun 20, 2018 – Oct 1, 2020 · Past); Keryx Biopharmaceuticals Inc (Director · May 29, 2018 – Dec 12, 2018 · Past)
Director · May 2, 2018 – Oct 16, 2024 · Past
Timothy M Mayleben
Other companies: Landos Biopharma Inc (Director · May 13, 2021 – May 23, 2024 · Past); Loxo Oncology Inc (Director · Jul 28, 2015 – Feb 15, 2019 · Past); Marinus Pharmaceuticals Inc (Director · Jul 31, 2014 – Feb 7, 2025 · Past); Esperion Therapeutics, Inc. (President & CEO, Director · Jun 25, 2013 – Jan 28, 2021 · Past)
President and CEO, Director · Oct 17, 2008 – Aug 29, 2012 · Past
Kevin F. McLaughlin
Other companies: Invivyd, Inc. (Director · Since at least May 21, 2024); Decibel Therapeutics Inc (Director · Oct 10, 2022 – Sep 25, 2023 · Past); Acceleron Pharma Inc (SVP, CFO and Treasurer · Jul 7, 2015 – Nov 19, 2021 · Past)
Director · Since at least Jan 6, 2015
Paul Wotton
Other companies: Ocata Therapeutics Inc (President and CEO, Director · Jul 21, 2014 – Feb 10, 2016 · Past); Genaera Corp (Director · Jun 26, 2008 – Aug 13, 2008 · Past); Antares Pharma Inc (President and CEO, Director · Jan 3, 2006 – May 29, 2014 · Past)
Director · Since at least Jan 6, 2015
Heidi Hagen
Other companies: Obsidian Therapeutics, Inc. (Director · Since at least Aug 3, 2026); Alaunos Therapeutics, Inc. (Director · Jun 13, 2019 – Sep 2, 2021 · Past)
Director · Since at least Aug 23, 2013
Scott Durbin
Other companies: Motus GI Holdings, Inc. (Director · Sep 6, 2023 – Mar 5, 2024 · Past); Viveve Medical, Inc. (Chief Executive Officer, Director · Jun 17, 2016 – Jan 3, 2023 · Past)
CFO · Jan 4, 2012 – Jan 4, 2012 · Past
Dominick Colangelo
Other companies: Trevi Therapeutics, Inc. (Director · Since at least Jun 29, 2020)
President and Chief Executive Officer · Since at least Mar 6, 2013
Jonathan Mark Hopper
Other companies: Osiris Therapeutics Inc (Chief Medical Officer · Nov 24, 2014 – Apr 12, 2016 · Past)
Chief Medical Officer · Since at least Feb 11, 2020
Sandra Pennell
Other companies: Delcath Systems, Inc. (CHIEF FINANCIAL OFFICER · Since at least Jun 1, 2023)
VP and Corporate Controller · Sep 30, 2020 – Sep 30, 2020 · Past
Alan L. RubinoDirector · Since at least Apr 29, 2026
All 24 people
PersonSeat
Brian GibsonVice President · Oct 13, 2011 – May 3, 2012 · Past
Gerald Brennan JrVP Admin. and Finance, CFO · Feb 16, 2006 – Nov 30, 2007 · Past
Jonathan SiegalPrincipal Accounting Officer · Since at least Feb 16, 2022
Joseph A. MaraChief Financial Officer · Since at least Jun 30, 2026
Joseph Anthony Mara JrChief Financial Officer · Since at least May 7, 2026
Karen MahoneyChief Human Resources Officer · Since at least Feb 19, 2025
Lisa WrightDirector · Since at least Jun 1, 2021
Michael HalpinChief Operating Officer · Since at least Jun 15, 2019
Nelson M SimsDirector · Oct 17, 2008 – Mar 20, 2015 · Past
Robert BardVP Reg-Clinic Affairs &, QS. · Sep 7, 2006 – Sep 7, 2006 · Past
Robert L. ZerbeDirector · Since at least Apr 29, 2026
Ronnda BartelChief Scientific Officer · Oct 16, 2006 – Jun 25, 2012 · Past
Sean C FlynnChief Legal Officer · Since at least Jun 18, 2026
Susan WyantDirector · Nov 2, 2006 – Nov 7, 2007 · Past

Open People

Log in to ask 6ix AI your own questions about Vericel Corporation.